Investigative Urology

Multiparameter Urine Analysis for Quantitative Bladder Cancer Surveillance of Orthotopic Xenografted Mice - Beyond the Abstract February 3, 2020

MDA-7/IL-24: A Potential Therapeutic for Prostate Cancer Bone Metastasis – Beyond the Abstract July 19, 2018

Myristoylation of Src Kinase Mediates Src-Induced and High-Fat Diet Accelerated Prostate Tumor Progression in Mice: Beyond the Abstract October 19, 2017

Induction of oxidants distinguishes susceptibility of prostate carcinoma cell lines to p53 gene transfer mediated by an improved adenoviral vector: Beyond the abstract May 10, 2017

Targeted hydroxyethyl starch prodrug for inhibiting the growth and metastasis of prostate cancer: Beyond the Abstract January 31, 2017

Whole exome sequencing of urachal adenocarcinoma reveals recurrent NF1 mutations: Beyond the Abstract November 16, 2016

RK-33 radiosensitizes prostate cancer cells by blocking the RNA helices DDX3: Beyond the Abstract October 13, 2016

Glycosylation is an Androgen-Regulated Process Essential for Prostate Cancer Cell Viability: Beyond the Abstract October 3, 2016

Regeneration and Carcinogenesis - Beyond the Abstract April 13, 2016

Beyond the Abstract - Treatment of prostate carcinoma with (Galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates, by Yuan Huang, et al June 6, 2012

Beyond the Abstract - Atorvastatin induces autophagy in prostate cancer PC3 cells through activation of LC3 transcription, by Wannian Yang, PhD, et al January 5, 2012

Beyond the abstract - Expression of ERβ and Its Co-Regulators p300 and NCoR in Human Transitional Cell Bladder Cancer, by Athanasios Papatsoris MD, MSc, PhD, FEBU, FES. November 30, 2011

Beyond the Abstract - p53 and cyclooxygenase-2 expression are directly associated with cyclin D1 expression in radical prostatectomy specimens of patients with hormone-naïve prostate cancer , by Panagiotis J. Vlachostergios. MD., Et Al. November 18, 2011

Beyond the Abstract - In vitro and in vivo responses of advanced prostate tumors to PSMA ADC, an auristatin-conjugated antibody to prostate-specific membrane antigen, by William Olson, PhD and Warren Heston, PhD November 11, 2011

Beyond the Abstract - Lovastatin causes diminished PSA secretion by inhibiting AR expression and function in LNCaP prostate cancer cells, by Lin Yang, PhD September 15, 2011

Beyond the Abstract - DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer, by Yuya Kobayashi, PhD August 18, 2011

Beyond the Abstract - Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: Results of a prospective study in a cli July 27, 2011

Beyond the Abstract - Genetic polymorphisms of CYP17A1, vitamin D receptor and androgen receptor in Italian heredo-familial and sporadic prostate cancers, by Tiziana Venesio, PhD, et al July 6, 2011

Beyond the Abstract - Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: A large multi-institutional study, by Carmen Mir and Alexandre R. Zlotta June 8, 2011

Beyond the Abstract - GSTT1: A marker of the aggressiveness of bladder cancer, by Yun-Sok Ha, MD, PhD April 15, 2011

Page 1 of 2